CD8A and neoplasm: Here, we apply a high-dimensional, integrated approach utilizing three human scRNA-seq data sets (with appropriate per-patient analysis), proteomic CODEX data, ex vivo systems, and murine models to identify an M2-independent, targetable, novel mechanism of tumor-reactive CD8+ T cell dysfunction specific to the liver.